| Coping styles and mental health in response to societal changes during the COVID-19 pandemic C Gurvich, N Thomas, EHX Thomas, AR Hudaib, L Sood, K Fabiatos, ... International journal of social psychiatry 67 (5), 540-549, 2021 | 295 | 2021 |
| Mental health outcomes associated with the use of amphetamines: A systematic review and meta-analysis R McKetin, J Leung, E Stockings, Y Huo, J Foulds, JM Lappin, ... EClinicalMedicine 16, 81-97, 2019 | 161 | 2019 |
| A systematic review of risk factors for methamphetamine-associated psychosis S Arunogiri, JA Foulds, R McKetin, DI Lubman Australian & New Zealand Journal of Psychiatry 52 (6), 514-529, 2018 | 95 | 2018 |
| A roadmap for integrating neuroscience into addiction treatment: a consensus of the neuroscience interest group of the international society of addiction medicine A Verdejo-Garcia, V Lorenzetti, V Manning, H Piercy, R Bruno, R Hester, ... Frontiers in psychiatry 10, 877, 2019 | 94 | 2019 |
| Reorganization of substance use treatment and harm reduction services during the COVID-19 pandemic: a global survey SR Radfar, CAJ De Jong, A Farhoudian, M Ebrahimi, P Rafei, M Vahidi, ... Frontiers in Psychiatry 12, 639393, 2021 | 92 | 2021 |
| Patient-reported outcomes of treatment of opioid dependence with weekly and monthly subcutaneous depot vs daily sublingual buprenorphine: a randomized clinical trial N Lintzeris, AJ Dunlop, PS Haber, DI Lubman, R Graham, S Hutchinson, ... JAMA Network Open 4 (5), e219041-e219041, 2021 | 88 | 2021 |
| A global survey on changes in the supply, price, and use of illicit drugs and alcohol, and related complications during the 2020 COVID-19 pandemic A Farhoudian, SR Radfar, H Mohaddes Ardabili, P Rafei, M Ebrahimi, ... Frontiers in psychiatry 12, 646206, 2021 | 77 | 2021 |
| Pregabalin misuse‐related ambulance attendances in Victoria, 2012–2017: characteristics of patients and attendances R Crossin, D Scott, S Arunogiri, K Smith, PM Dietze, DI Lubman Medical journal of Australia 210 (2), 75-79, 2019 | 62 | 2019 |
| Tracing the affordances of long-acting injectable depot buprenorphine: a qualitative study of patients’ experiences in Australia A Barnett, M Savic, N Lintzeris, R Bathish, S Arunogiri, AJ Dunlop, ... Drug and Alcohol Dependence 227, 108959, 2021 | 54 | 2021 |
| Synthetic cannabinoid use disorder: an update for general psychiatrists J Grigg, V Manning, S Arunogiri, DI Lubman Australasian Psychiatry 27 (3), 279-283, 2019 | 33 | 2019 |
| Trends in gamma‐hydroxybutyrate‐related harms based on ambulance attendances from 2012 to 2018 in Victoria, Australia S Arunogiri, F Moayeri, R Crossin, JJ Killian, K Smith, D Scott, DI Lubman Addiction 115 (3), 473-479, 2020 | 29 | 2020 |
| Interim guidance for the delivery of medication assisted treatment of opioid dependence in response to COVID-19: a national response N Lintzeris, V Hayes, S Arunogiri Sydney: The Australasian Professional Society on Alcohol and other Drugs (ASPAD), 2020 | 29 | 2020 |
| Depot buprenorphine during COVID-19 in Australia: opportunities and challenges S Arunogiri, N Lintzeris Journal of Substance Abuse Treatment 124, 108221, 2021 | 28 | 2021 |
| Harm reduction and abstinence-based models for treatment of substance use disorders during the COVID-19 pandemic: a global perspective VL Narasimha, JL Butner, E Hanafi, M Farokhnia, R Bhad, F Chalabianloo, ... BJPsych International 19 (3), 66-69, 2022 | 22 | 2022 |
| N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial R McKetin, OM Dean, A Turner, PJ Kelly, B Quinn, DI Lubman, P Dietze, ... EClinicalMedicine 38, 2021 | 22 | 2021 |
| Anxiety and substance use disorders: A worrying combination S Arunogiri, DI Lubman Australasian Psychiatry 23 (4), 382-387, 2015 | 22 | 2015 |
| The methamphetamine-associated psychosis spectrum: a clinically focused review S Arunogiri, R McKetin, A Verdejo-Garcia, DI Lubman International Journal of Mental Health and Addiction 18 (1), 54-65, 2020 | 21 | 2020 |
| A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy … R McKetin, OM Dean, A Turner, PJ Kelly, B Quinn, DI Lubman, P Dietze, ... Trials 20, 1-11, 2019 | 21 | 2019 |
| Methamphetamine treatment guidelines: practice guidelines for health professionals J Grigg, V Manning, S Arunogiri, I Volpe, M Frei, V Phan, A Rubenis, ... Turning Point, 2018 | 21 | 2018 |
| Dysfunctional personality beliefs and emotion recognition in individuals with methamphetamine dependence L Hanegraaf, S Arunogiri, J Hohwy, A Verdejo-Garcia Addictive Behaviors 105, 106336, 2020 | 20 | 2020 |
Prof Dan LubmanTurning Point and Monash UniversityПідтверджена електронна адреса в monash.edu